Related Experiment Videos
Heart disease, cancer, and stroke in Maryland
1Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore 21201.
Insights
Maryland faces high premature death rates from heart disease, cancer, and stroke (HCS). A comprehensive intervention campaign is planned to reduce HCS morbidity, mortality, and costs.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Maryland exhibits elevated mortality rates for heart disease, cancer, and stroke (HCS) compared to national averages.
- Over half of HCS-related deaths in Maryland are premature (before age 75).
- These diseases impose a substantial economic burden, with annual healthcare and indirect costs approximating $4.4 billion.
Purpose of the Study:
- To address the significant public health burden of heart disease, cancer, and stroke (HCS) in Maryland.
- To highlight the need for a coordinated, comprehensive intervention campaign to reduce HCS-related morbidity and mortality.
- To propose a planned intervention campaign by the University of Maryland at Baltimore.
Main Methods:
- Review of scientific literature on HCS prevention strategies.
- Analysis of HCS mortality rates and economic costs in Maryland.
- Planning of a systematic, well-coordinated intervention campaign.
Main Results:
- Maryland's HCS mortality rates exceed national levels.
- A significant portion of HCS deaths are premature, indicating preventable loss.
- Current state-level interventions are insufficient to combat the HCS burden.
Conclusions:
- A comprehensive, coordinated intervention campaign is essential for reducing HCS morbidity, mortality, and associated costs in Maryland.
- The planned campaign by the University of Maryland at Baltimore offers a model for addressing this public health challenge.
- Similar systematic interventions are recommended for other states facing comparable HCS burdens.
Abstract:
Maryland has higher mortality rates from heart disease, cancer, and stroke (HCS) than the United States as a whole. More than 50% of deaths from HCS are premature, occurring before age 75. The health care and indirect costs from these three diseases total approximately $4.4 billion annually, placing a major economic burden on the state. A large body of scientific literature has shown the potential for the prevention of HCS. Currently, Maryland, like virtually all states, lacks the type of systematic, well-coordinated, comprehensive intervention campaign needed to lower morbidity, mortality, and health care costs from these three diseases. Such a campaign has now been planned by the University of Maryland at Baltimore. Similar campaigns are needed throughout much of the United States.